These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 11595658)

  • 1. N-glycosylation of CRF receptor type 1 is important for its ligand-specific interaction.
    Assil IQ; Abou-Samra AB
    Am J Physiol Endocrinol Metab; 2001 Nov; 281(5):E1015-21. PubMed ID: 11595658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ligand-selective domains of corticotropin-releasing factor type 1 and type 2 receptor reside in different extracellular domains: generation of chimeric receptors with a novel ligand-selective profile.
    Dautzenberg FM; Kilpatrick GJ; Wille S; Hauger RL
    J Neurochem; 1999 Aug; 73(2):821-9. PubMed ID: 10428081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a Pachymedusa dacnicolor-Sauvagine analog as a new high-affinity radioligand for corticotropin-releasing factor receptor studies.
    Perrin MH; Tan LA; Vaughan JM; Lewis KA; Donaldson CJ; Miller C; Erchegyi J; Rivier JE; Sawchenko PE
    J Pharmacol Exp Ther; 2015 May; 353(2):307-17. PubMed ID: 25736419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Juxtamembrane region of the amino terminus of the corticotropin releasing factor receptor type 1 is important for ligand interaction.
    Assil IQ; Qi LJ; Arai M; Shomali M; Abou-Samra AB
    Biochemistry; 2001 Feb; 40(5):1187-95. PubMed ID: 11170443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 125I-Tyro-sauvagine: a novel high affinity radioligand for the pharmacological and biochemical study of human corticotropin-releasing factor 2 alpha receptors.
    Grigoriadis DE; Liu XJ; Vaughn J; Palmer SF; True CD; Vale WW; Ling N; De Souza EB
    Mol Pharmacol; 1996 Sep; 50(3):679-86. PubMed ID: 8794910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cloning and functional pharmacology of two corticotropin-releasing factor receptors from a teleost fish.
    Pohl S; Darlison MG; Clarke WC; Lederis K; Richter D
    Eur J Pharmacol; 2001 Nov; 430(2-3):193-202. PubMed ID: 11711031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping of the ligand-selective domain of the Xenopus laevis corticotropin-releasing factor receptor 1: implications for the ligand-binding site.
    Dautzenberg FM; Wille S; Lohmann R; Spiess J
    Proc Natl Acad Sci U S A; 1998 Apr; 95(9):4941-6. PubMed ID: 9560207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding differences of human and amphibian corticotropin-releasing factor type 1 (CRF(1)) receptors: identification of amino acids mediating high-affinity astressin binding and functional antagonism.
    Dautzenberg FM; Wille S
    Regul Pept; 2004 May; 118(3):165-73. PubMed ID: 15003833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for the abundant expression of arginine 185 containing human CRF(2alpha) receptors and the role of position 185 for receptor-ligand selectivity.
    Dautzenberg FM; Huber G; Higelin J; Py-Lang G; Kilpatrick GJ
    Neuropharmacology; 2000 Jun; 39(8):1368-76. PubMed ID: 10818253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alanine scanning mutagenesis of the second extracellular loop of type 1 corticotropin-releasing factor receptor revealed residues critical for peptide binding.
    Gkountelias K; Tselios T; Venihaki M; Deraos G; Lazaridis I; Rassouli O; Gravanis A; Liapakis G
    Mol Pharmacol; 2009 Apr; 75(4):793-800. PubMed ID: 19124613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single amino acid serves as an affinity switch between the receptor and the binding protein of corticotropin-releasing factor: implications for the design of agonists and antagonists.
    Eckart K; Jahn O; Radulovic J; Tezval H; van Werven L; Spiess J
    Proc Natl Acad Sci U S A; 2001 Sep; 98(20):11142-7. PubMed ID: 11572971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel high-affinity photoactivatable antagonists of corticotropin-releasing factor (CRF) photoaffinity labeling studies on CRF receptor, type 1 (CRFR1).
    Bonk I; Rühmann A
    Eur J Biochem; 2000 May; 267(10):3017-24. PubMed ID: 10806401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligand affinity for amino-terminal and juxtamembrane domains of the corticotropin releasing factor type I receptor: regulation by G-protein and nonpeptide antagonists.
    Hoare SR; Sullivan SK; Schwarz DA; Ling N; Vale WW; Crowe PD; Grigoriadis DE
    Biochemistry; 2004 Apr; 43(13):3996-4011. PubMed ID: 15049707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular cloning of a type A chicken corticotropin-releasing factor receptor with high affinity for urotensin I.
    Yu J; Xie LY; Abou-Samra AB
    Endocrinology; 1996 Jan; 137(1):192-7. PubMed ID: 8536612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An oxidation resistant radioligand for corticotropin-releasing factor receptors.
    Assil IQ; Shomali ME; Abou-Samra AB
    Peptides; 2001 Jul; 22(7):1055-61. PubMed ID: 11445234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localization of agonist- and antagonist-binding domains of human corticotropin-releasing factor receptors.
    Liaw CW; Grigoriadis DE; Lorang MT; De Souza EB; Maki RA
    Mol Endocrinol; 1997 Dec; 11(13):2048-53. PubMed ID: 9415408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corticotropin-releasing factor-binding protein (CRF-BP) inhibits CRF- and urotensin-I-mediated activation of CRF receptor-1 and -2 in common carp.
    Manuel R; Metz JR; Flik G; Vale WW; Huising MO
    Gen Comp Endocrinol; 2014 Jun; 202():69-75. PubMed ID: 24769042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sauvagine cross-links to the second extracellular loop of the corticotropin-releasing factor type 1 receptor.
    Assil-Kishawi I; Abou-Samra AB
    J Biol Chem; 2002 Sep; 277(36):32558-61. PubMed ID: 12029097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [¹²⁵I]YP20: a novel radioligand specific for the extracellular domain of the CRF₁ receptor.
    Gordon JC; Edwards P; Elmore CS; Lazor LA; Paschetto K; Bostwick R; Sylvester M; Mauger R; Scott C; Aharony D
    Eur J Pharmacol; 2010 Dec; 649(1-3):59-63. PubMed ID: 20854803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Internalization of the human CRF receptor 1 is independent of classical phosphorylation sites and of beta-arrestin 1 recruitment.
    Rasmussen TN; Novak I; Nielsen SM
    Eur J Biochem; 2004 Nov; 271(22):4366-74. PubMed ID: 15560778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.